John T. Lonsdale - Concepedia

Author

John T. Lonsdale

Also Known As

, Biospecimen Collection Source Site—NDrI, Bureau of Economic Geology, J T Lonsdale, J. Lonsdale, J. T. LONSDALE, J. T. Lonsdale, J.T. Lonsdale, John H. Dietrich, John Lonsdale

Publications

20.3K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Icahn School of Medicine at Mount Sinai Stanford University University of Geneva National Institutes of Health

About

John T. Lonsdale is an author at GlaxoSmithKline (United States) specializing in medicine, biochemistry, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	918
2	Biochemistry	8	8	801
3	Natural Sciences	4	4	398
4	Engineering	3	3	62
5	Public Health	2	2	278

John T. Lonsdale

Publications

8.5K

Citations

H-Index

Page 1

	Year	Citations
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans Kristin G. Ardlie, David S. DeLuca, Ayellet V. Segrè, Science	2015	5.5K
Effect of predicted protein-truncating genetic variants on the human transcriptome Manuel A. Rivas, Matti Pirinen, Donald F. Conrad, Science	2015	326
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs Edward A. Weinstein, Takahiro Yano, Linsheng Li, Proceedings of the National Academy of Sciences	2005	289
The Genotype-Tissue Expression (GTEx) project John T. Lonsdale, Jeffrey A. Thomas, Mike Salvatore, Nature Genetics GeneticsGenetic EpidemiologyGene CharacterizationMolecular GeneticsDisease Gene Identification	2013	265
Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases Jialiang Yang, Tao Huang, Francesca Petralia, Scientific Reports	2015	222
Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli Philip E. Brandish, Ken‐ichi Kimura, M Inukai, Antimicrobial Agents and Chemotherapy Escherichia ColiAntibacterial Agents TumicamycinAntimicrobial ChemotherapyChemical BiologyDrug Resistance	1996	200
Refined structures of β-ketoacyl-acyl carrier protein synthase III Xiayang Qiu, Cheryl A. Janson, Ward W. Smith, Journal of Molecular Biology Protein BiosynthesisBiochemistry	2001	183
Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery David Payne, Patrick V. Warren, David Holmes, Drug Discovery Today Antimicrobial Drug DiscoveryBiosynthesisBacterial Fatty-acid BiosynthesisBiochemistryNatural Product Biosynthesis	2001	143
Purification and Biochemical Characterization of theMycobacterium tuberculosis β-Ketoacyl-acyl Carrier Protein Synthases KasA and KasB Merrill L. Schaeffer, Gautam Agnihotri, Craig Volker, Journal of Biological Chemistry	2001	141
Crystal Structure of β-Ketoacyl-Acyl Carrier Protein Synthase III Xiayang Qiu, Cheryl A. Janson, Alex K. Konstantinidis, Journal of Biological Chemistry	1999	140

Page 1